teduglutide 0.05 mg/kg/d

DRUG2 trials

Sponsors

Shire

Conditions

Short Bowel Syndrome

Phase 3

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

CompletedNCT00081458

ShireShort Bowel Syndrome

Start: 2004-05-25End: 2007-07-06Updated: 2021-06-09

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

CompletedNCT00172185

ShireShort Bowel Syndrome

Start: 2005-01-10End: 2008-01-24Updated: 2021-06-02

Related Papers

Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials

Therapeutic Advances in Gastroenterology2020-01-0150 citations

Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.

2016-11-2359 citations

Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide

Journal of Parenteral and Enteral Nutrition2016-08-0912 citations

Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.

2013-01-17111 citations

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.

2011-02-11288 citations